# A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer

> **NCT00717951** · PHASE2 · UNKNOWN · sponsor: **Academy Military Medical Science, China** · enrollment: 120 (actual)

## Conditions studied

- Advanced Breast Cancer

## Interventions

- **DRUG:** docetaxol, cisplatin, capecitabine

## Key facts

- **NCT ID:** NCT00717951
- **Lead sponsor:** Academy Military Medical Science, China
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-05
- **Primary completion:** 2009-12
- **Final completion:** 2010-05
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2008-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00717951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00717951, "A Randomised,Multi-Center Study of Docetaxol Plus Capecitabine or Cisplatin in Anthracycline-Pretreated Patients With Advanced Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00717951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*